May 22, 2014 / 3:53 PM / 3 years ago

BRIEF-Thrombogenics NV says to provide update on strategic review in due course

May 22 (Reuters) - Thrombogenics Nv

* Strategic review is ongoing. An update will be provided in due course

* Cash of eur 156.9 million on hand at end of March 2014, compared to eur 172.4 million at end of December 2013 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below